Evidence map›Paper›PMID 24956111›Full record

ArticlePloS one2014

Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Lisa Natoli, Lisa Maher, Mark Shephard, Belinda Hengel, Annie Tangey, Steven G Badman, James Ward, Rebecca J Guy, TTANGO Investigators

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Biomolecules · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa NatoliThe Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia; The Burnet Institute, Melbourne, Victoria, Australia.
Lisa MaherThe Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Mark ShephardFlinders University International Centre for Point of-Care Testing, Flinders University, Adelaide, South Australia, Australia.
Belinda HengelApunipima Cape York Health Council, Cairns, Queensland, Australia.
Annie TangeyNgaanyatjarra Health Service, Alice Springs, Northern Territory, Australia.
Steven G BadmanThe Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
James WardBaker IDI, Alice Springs, Northern Territory, Australia.
Rebecca J GuyThe Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
TTANGO Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPoint-of-care (POC) testing for chlamydia (CT) and gonorrhoea (NG) offers a new approach to the diagnosis and management of these sexually transmitted infections (STIs) in remote Australian communities and other similar settings. Diagnosis of STIs in remote communities is typically symptom driven, and for those who are asymptomatic, treatment is generally delayed until specimens can be transported to the reference laboratory, results returned and the patient recalled. The objective of this study was to explore the clinical implications of using CT/NG POC tests in routine clinical care in remote settings.

methodsIn-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with a range of sexual health and laboratory expertise.

resultsParticipants highlighted the potential impact POC testing would have on different stages of the current STI management pathway in remote Aboriginal communities and how the pathway would change. They identified implications for offering a POC test, specimen collection, conducting the POC test, syndromic management of STIs, pelvic inflammatory disease diagnosis and management, interpretation and delivery of POC results, provision of treatment, contact tracing, management of client flow and wait time, and re-testing at 3 months after infection.

conclusionsThe introduction of POC testing to improve STI service delivery requires careful consideration of both its advantages and limitations. The findings of this study will inform protocols for the implementation of CT/NG POC testing, and also STI testing and management guidelines.

Indexed as

AdultAustraliaChlamydiaChlamydia InfectionsDisease ManagementFemaleFollow-Up StudiesGonorrheaHumansLaboratoriesMaleMiddle AgedNeisseria gonorrhoeaePoint-of-Care SystemsPrognosisQualitative Research

Identifiers

PMID24956111
PMCPMC4067364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.